These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34747523)

  • 21. On the efficiency of two-stage response-adaptive designs.
    Dette H; Bornkamp B; Bretz F
    Stat Med; 2013 May; 32(10):1646-60. PubMed ID: 22865374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive designs for confirmatory clinical trials.
    Bretz F; Koenig F; Brannath W; Glimm E; Posch M
    Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of number of subjects required for comparison of drug versus control in adaptive designs.
    Hu FF; Hu JH
    Ann Acad Med Singap; 2000 Sep; 29(5):565-9. PubMed ID: 11126689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional and unconditional confidence intervals following a group sequential test.
    Fan X; DeMets DL
    J Biopharm Stat; 2006; 16(1):107-22. PubMed ID: 16440840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical strategies for operationalizing optimal allocation in stratified cluster-based outcome-dependent sampling designs.
    Sauer S; Hedt-Gauthier B; Haneuse S
    Stat Med; 2023 Mar; 42(7):917-935. PubMed ID: 36650619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size re-estimation for covariate-adaptive randomized clinical trials.
    Li X; Ma W; Hu F
    Stat Med; 2021 May; 40(12):2839-2858. PubMed ID: 33733513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of statistical approaches for adaptive designs and design modifications.
    Schäfer H; Timmesfeld N; Müller HH
    Biom J; 2006 Aug; 48(4):507-20. PubMed ID: 16972702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inference in response-adaptive clinical trials when the enrolled population varies over time.
    Russo M; Ventz S; Wang V; Trippa L
    Biometrics; 2023 Mar; 79(1):381-393. PubMed ID: 34674228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A general formulation for a one-sided group sequential design.
    Moser BK; George SL
    Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confidence intervals and sample sizes.
    Grieve AP
    Biometrics; 1991 Dec; 47(4):1597-602; discussion 1602-3. PubMed ID: 1786333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size re-estimation for pivotal clinical trials.
    Liu Y; Xu H
    Contemp Clin Trials; 2021 Mar; 102():106215. PubMed ID: 33217555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capture-recapture when time and behavioral response affect capture probabilities.
    Chao A; Chu W; Hsu CH
    Biometrics; 2000 Jun; 56(2):427-33. PubMed ID: 10877300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stepwise two-stage sample size adaptation.
    Wan H; Ellenberg SS; Anderson KM
    Stat Med; 2015 Jan; 34(1):27-38. PubMed ID: 25252082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized test-treatment studies with an outlook on adaptive designs.
    Hot A; Bossuyt PM; Gerke O; Wahl S; Vach W; Zapf A
    BMC Med Res Methodol; 2021 Jun; 21(1):110. PubMed ID: 34074263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the relative efficiency of model-assisted designs: a conditional approach.
    Lin R; Yuan Y
    J Biopharm Stat; 2019; 29(4):648-662. PubMed ID: 31258039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A natural lead-in approach to response-adaptive allocation for continuous outcomes.
    Donahue E; Sabo RT
    Pharm Stat; 2021 May; 20(3):563-572. PubMed ID: 33484036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation in flexible two stage designs.
    Brannath W; König F; Bauer P
    Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.